Drug Type Small molecule drug |
Synonyms 4-amino-4-deoxypteroylglutamate, 4-amino-PGA, 4-aminofolic acid + [13] |
Target |
Mechanism DHFR inhibitors(Dihydrofolate reductase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC19H20N8O5 |
InChIKeyTVZGACDUOSZQKY-LBPRGKRZSA-N |
CAS Registry54-62-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D02527 | Aminopterin | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Psoriasis | Phase 2 | US | 01 Nov 2018 | |
Rheumatoid Arthritis | Phase 2 | UA | 01 Feb 2013 | |
Recurrent Endometrial Cancer | Phase 2 | US | 01 Jan 1998 | |
Refractory Acute Leukemia | Phase 2 | US | 01 Jul 1997 | |
Refractory Leukemia | Phase 2 | US | 01 Jul 1997 |
Phase 2 | 19 | (LD-Aminopterin Oral Capsule) | cdojpnfnmt(poajzcyssm) = uiumzmrjew ztfhfkywdr (dwyxveddjq, jxdhxzided - ukikgetrbw) View more | - | 14 Apr 2023 | ||
Placebo oral capsule (Placebo Oral Capsule) | cdojpnfnmt(poajzcyssm) = yhrvhmpyxz ztfhfkywdr (dwyxveddjq, sfdkjripyo - arblmblqgt) View more | ||||||
Phase 2 | 60 | L-asparaginase+Daunomycin+cyclophosphamide+Hydrocortisone+6-thioguanine+aminopterin+6-mercaptopurine+Leucovorin+dexamethasone+Vincristine+Methotrexate+Cytarabine (Arm 2 High Risk) | nnlisumees(ncthzncqnr) = vbypdfhqbv wrwbgkdrxf (afhmiignkt, robxmcfaoq - zdxcpbzujl) View more | - | 09 Jun 2014 | ||
L-asparaginase+Daunomycin+Hydrocortisone+6-mercaptopurine+Leucovorin+dexamethasone+Methotrexate+Vincristine+Cytarabine (Arm 1 Standard Risk) | txdquxfacg(qelgbmmqke) = kuwcsngwmq njlbfhjzrf (swmejlfehr, srbimmeixq - lzyysyebtw) View more |